Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Source: pharmiweb.com
📰 Imke Meyer News
Imke Meyer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Imke Meyer. Real-time updates on events, politics, business and more.
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded...
Source: marketscreener.com
Affini-T Therapeutics, Inc.: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil.
United States Fred Hutchinson Cancer Research Center Al Iskandariyah Fred Hutch Aude Chapuis Imke Meyer
Source: finanznachrichten.de